Nellcor Device Sitting-Walking Test for Pulse Oximetry
Official title: Feasibility of the Investigational Nellcor™ Investigational Device During Non-Motion and Walking Motion Conditions in Adult Volunteers
Run by Medtronic - MITG · NCT07234279 · Data updated 2026-11-12
This study tests how accurately the Nellcor device measures heart rate and blood oxygen levels when people are resting and walking.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Medtronic - MITG Industry-sponsored |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Denver, Colorado) |
| Status | Recruiting |
| Started | August 11, 2026 |
| Main results expected | October 30, 2026 |
| Study ends | October 30, 2026 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT07234279 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–<75 years who can participate for the full study duration, weigh over 40 kg, are non-smokers or quit within 36 hours, and can consent.
✕Probably not a fit
Individuals with finger or hand injuries, conditions affecting blood flow, severe allergies to sensor adhesives, pregnancy potential, morbid obesity (BMI >39.5), or weight >136 kg may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the accuracy of the Nellcor Investigational Device for measuring pulse rate and oxygen saturation in adults during non-movement and walking. It uses non-invasive sensors across a diverse patient population to compare readings under different activity conditions. Enrollment includes adults 18 to under 75 who meet weight and health criteria and can consent. The study is conducted at a clinical physiology lab in Denver, with Medtronic as lead sponsor. Results may inform device performance in real-world use cases involving mobility.
Why it matters
Potential benefit: If successful, the device could provide reliable non-invasive monitoring of heart rate and oxygen levels during daily activities.
How similar studies have gone: Previous similar sensor studies have shown variable performance; this study builds on established approaches but remains observational with exploratory aims.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female participants ≥18 years of age, and \<75 years of age. * Participant is able to participate for the duration of the study * Participant is willing to sign an informed consent form (ICF) * Participant weighs \> 40kg * Participants must be a non-smoker or not have smoked within 36 hours prior to the study Exclusion Criteria: * Participant self-reported prior injury or trauma to fingers or hands, which in the opinion of the investigator, may change blood flow or vascular supply and affect the ability to test sensors * Physiologic abnormalities that prevent proper application of pulse oximetry sensor * Severe contact allergies that cause a reaction to standard adhesive materials such as those found in medical sensors and electrodes * Individuals of childbearing potential who are self-reported as pregnant, or who are self-reported as trying to get pregnant * Morbid obesity (defined as BMI \> 39.5) * Weight \> 136 kg * Participants who self-report problems of unsteadiness or imbalance issues and/or who are unable to walk on a treadmill without holding onto the handrails * Participant self-reported known heart or cardiovascular conditions such as: * Uncontrolled hypertension (Systolic pressure ≥ 140mmHg or Diastolic pressure \> 90mmHg on 3 consecutive readings day of screening) * Heart arrhythmias other than sinus arrhythmia (Self-reported and/or as identified on ECG day of screening). * History of heart attack, blocked artery, history of myocardial ischemia, angina, myocardial infarction, congestive heart failure, cardiomyopathy, stroke, transient ischemic attack, or carotid artery disease * Participants with self-reported clotting disorders, such as: * History of bleeding disorders or personal history of prolonged bleeding from injury * History of blood clots * Hemophilia * Current use of prescription blood thinner * Participants with other self-reported, known health conditions, such as: * Diabetes * Thyroid disease * Kidney disease / chronic renal impairment * History of seizures (except childhood febrile seizures), epilepsy, or unexplained syncope * Recent history of frequent migraine headaches, as determined medically relevant by the PI * History of head injury, as determined medically relevant by the PI * Cancer / chemotherapy * Sickle cell disease * History of hospital admission or a surgical procedure in the 60 days prior to study enrollment (self-reported) * Participants with any contraindications to protocol specific repositioning techniques * Unwillingness or inability to remove colored nail polish from test digit(s) * Participants who have self-reported health conditions beyond what is captured in the prior exclusion criteria, which in the opinion of the Investigator and/or Clinical Staff would classify the participant as medically unsuitable
Where it's running
-
Clinical Physiology Lab
Denver, Colorado, United States Recruiting
Study contacts
- Study coordinator: Hannah Bowman
- Email: Hannah.bowman@medtronic.com
- Phone: 720-930-1695
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pilates breathing vs diaphragmatic breathing after PCI
This study tests whether Pilates breathing or diaphragmatic breathing helps improve oxygen levels and heart-rate variability in people who just had PCI.
-
Alternate Nostril Breathing vs Diaphragmatic Breathing after PCI
Post-PCI patients will try two breathing techniques to see which helps keep oxygen levels steady and heart-rate variability better.
-
Measuring oxygen levels during intense squat exercises
This study is testing how intense squat exercises affect oxygen levels and fatigue in active individuals to see how hard they can push themselves.
-
Validation of a device for monitoring vital signs in children
This study is testing a new device called the VT-Patch® to see if it accurately measures vital signs like heart rate and temperature in children with different skin colors.
-
Contactless measurement of vital signs using a camera-based system
This study is testing a new camera system that measures vital signs like blood pressure and heart rate without touching the patient to see if it works well for everyone and helps reduce infection risk.
-
Impact of Kangaroo Care on Weight Gain in Preterm Infants
This study is testing if holding preterm infants skin-to-skin during their first feeding helps them gain weight better than if they are held during their second feeding.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.